1997;95:2098 107. 42. Lalani T, Chu VH, Park LP, et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med. 2013;173:1495 504. 1. Erba PA, Habib G, Glaudemans AWJM, et al. The round table approach in infective endocarditis & cardiovascular implantable electronic devices infections: make your e-Team come true. Eur J Nucl Med Mol Imaging. 2017;44:1107 8. 2. Chirillo F, Scotton P, Rocco F, et al. Impact of a multidisciplinary manage- ment strategy on the outcome of patients with native valve infective en- docarditis. Am J Cardiol. 2013;112:1171 6. 3. Botelho-Nevers E, Thuny F, Casalta JP, et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med. 2009;169:1290 8. 4. Thuny F, Grisoli D, Collart F, et al. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379:965 75. 5. Gaca JG, Sheng S, Daneshmand MA, et al. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Car- diovasc Surg. 2011;141:98 106.e1 2. 6. Sambola A, Fern ndez-Hidalgo N, Almirante B, et al. Sex differences in native-valve infective endocarditis in a single tertiary-care hospital. Am J Cardiol. 2010;106:92 8. 7. Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297:1354 61. 8. Lalani T, Chu VH, Park LP, et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med. 2013;173:1495 504. 9. Nagpal A, Sohail MR, Steckelberg JM. Prosthetic valve endocarditis: state of the heart. Clin Invest. 2012;2:803 17. 10. Jault F, Gandjbakhch I, Rama A, et al. Active native valve endocarditis: determinants of operative death and late mortality. Ann Thorac Surg. 1997;63:1737 41. 11. Hasbun R, Vikram HR, Barakat LA, et al. 